CITALOPRAM HYDROBRO
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded contract SPE2DP26F0541 to DMS Pharmaceutical Group Inc. as a delivery order under the broader commercial items award SPE2DX25D9900. The primary delivery order was intended for the procurement of Citalopram Hydrobromide, identified by NSN 6505015054632. This activity falls under the oversight of the DLA Troop Support Medical Supply Chain FSB, which had previously established a larger commercial items award with the vendor totaling 19,999,999.00 dollars. On August 26, 2026, modification P00001 was issued to contract SPE2DP26F0541. This supplemental agreement executed a termination for the government's convenience in accordance with FAR 52.212-4(c). As a result of this modification, CLIN 0001 was cancelled at no cost to the government, reducing the total value of this specific contract from 6.88 dollars to 0.00 dollars.
General Info
Place of Performance
Not specifiedSet-Aside
Documents
2AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
